University of Tennessee
FDA 503B outsourcing facility
Memphis, Tennessee
Key Takeaways
- FDA-registered 503B outsourcing facility since 2024
- Sterile compounding from bulk substances: Yes
- Not yet inspected by the FDA
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- May 19, 2024
- Most recent registration
- March 25, 2026
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- Not yet inspected
University of Tennessee has registered with the FDA as a 503B outsourcing facility but has not yet been inspected. The FDA inspects registered facilities on a risk-based schedule once drug production and distribution are confirmed.
Compounded peptides and GLP-1s
University of Tennessee has not assigned NDCs or filed product reports in the most recent FDA reporting periods. 503B outsourcing facilities are a primary supply route for compounded peptides and GLP-1s during FDA-listed shortages; PeptideGrids grades the evidence for each, including Semaglutide, Tirzepatide, BPC-157, Retatrutide. Browse the GLP-1 and therapeutic peptide databases.
Location
875 Union Ave, Memphis, TN 38103
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Harry Kochat, 1-901-448-1440. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of University of Tennessee with the Tennessee Board of Pharmacy.
503B facilities in Tennessee
Tennessee has 2 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in Tennessee.
Frequently asked questions
Is University of Tennessee registered with the FDA?
Yes. University of Tennessee is a registered 503B outsourcing facility, first registered with the FDA on May 19, 2024 and most recently registered on March 25, 2026.
Has University of Tennessee been inspected by the FDA?
University of Tennessee has registered with the FDA but has not yet been inspected as a 503B outsourcing facility.
Has University of Tennessee had any FDA drug recalls?
No FDA drug recalls are matched to University of Tennessee in the openFDA enforcement database.
What does University of Tennessee compound?
University of Tennessee has not filed product reports with NDC-assigned drugs in the most recent FDA reporting periods.
Where is University of Tennessee located?
University of Tennessee is located in Memphis, Tennessee (875 Union Ave).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by University of Tennessee. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.